Static Chart StemRIM

Stocks

Delayed Japan Exchange 21:04:34 2026-08-31 EDT			5-day change	1st Jan Change
342.00 ^JPY	+3.01%		-3.39%	+30.04%

07-22	Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders	CI
07-08	StemRIM Inc. Announces Patent Registration For Stem Cell Gene Therapy Technology SR-GT1 Aimed At Curative Treatment Of Dystrophic Epidermolysis Bullosa In South Korea	CI

Duration

Period